HIF1A and glioblastoma: Moreover, the immunohistochemistry (IHC) and in situ hybridization (ISH) demonstrated that the recurrent tumors exhibited significantly higher HIF-1α and miR-26a staining intensity compared with primary tumors on the same set of GBM tissue (Fig. 6d).